Efficacy and safety of gadopiclenol versus gadoteric acid‑enhanced MRA in adult patients with suspected vascular disease
- Substances:Gadoteric Acid
Germany- Participants:18–64 years · 65+ years
- Substances:Gadoteric Acid
Rare diseases
Investigational molecules
Locations
Back to Germany356 clinical trials in Luebeck, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer types, including metastatic prostate cancer, breast cancer, and non-small cell lung cancer. Studies evaluate novel therapeutic approaches and combination treatments.
Investigating groundbreaking treatments targeting specific genetic markers and exploring immunotherapy combinations.
Innovative research addressing acute cerebral ischemic stroke and amyotrophic lateral sclerosis (ALS). Studies focus on improving patient outcomes and testing new therapeutic agents.
Evaluating novel compounds to enhance neurological function and patient quality of life.
Research into VEXAS syndrome and systemic autoimmune rheumatic diseases. Studies examine innovative treatments for complex inflammatory conditions.
Testing new therapeutic approaches for rare and challenging autoimmune conditions.
Clinical trials investigating treatments for hidradenitis suppurativa and atopic dermatitis. Research focuses on innovative therapies for chronic skin conditions.
Evaluating new therapeutic options for improving patient outcomes in persistent skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.